Hearings » Why Does the U.S. Department of Veterans Affairs Continue to Give a Suicide–Inducing Drug to Veterans with Post Traumatic Stress Disorder?
|
10:00AM Full Committee
Why Does the U.S. Department of Veterans Affairs Continue to Give a Suicide–Inducing Drug to Veterans with Post Traumatic Stress Disorder?
|
Opening Statements
- Hon. Bob Filner Chairman, and a Representative in Congress from the State of California
- Hon. Steve Buyer, Ranking Repubican Member, and a Representative in Congress from the State of Indiana
- Hon. Harry E. Mitchell, a Representative in Congress from the State of Arizona
- Hon. John T. Salazar, a Representative in Congress from the State of Colorado
- Hon. Steve Scalise, a Representative in Congress from the State of Louisiana
Witness Testimonies
Panel 1
- James G. Elliott, Silver Spring, MD, (Iraq War Veteran)
- Accompanied By:
- Tammy R. Hilburn, Silver Spring, MD
- Lieutenant Colonel Roger G. Charles, USMC (Ret.), Vice-Chairman, Board of Trustees, Soldiers for the Truth Foundation, and Editor, DefenseWatch, on behalf of Eilhys England Hackworth, Chairperson, Board of Trustees, Soldiers for the Truth Foundation
Panel 2
- The Honorable James B. Peake, M.D., Secretary, U.S. Department of Veterans Affairs
- Accompanied By:
- Joel Kupersmith, M.D., Chief Research and Development Officer, Veterans Health Administration, U.S. Department of Veterans Affairs
- J. Thomas Puglisi, Ph.D., CIP, Chief Officer, Office Research Oversight, Veterans Health Administration, U.S. Department of Veterans Affairs
- Miles McFall, Ph.D., Director, Post-Traumatic Stress Disorder Treatment Programs, Veterans Affairs Puget Sound Health Care System, Veterans Health Administration, U.S. Department of Veterans Affairs
- Paul Seligman, M.D., M.P.H, Associate Director of Safety Policy and Communication, Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services
- Accompanied By:
- Robert Temple, M.D., Director, Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services
Panel 3
- Ponni Subbiah, M.D., M.P.H., Vice President, Medical Affairs, Pfizer Inc., New York, NY
- John D. Daigh, Jr., M.D., CPA, Assistant Inspector General for Healthcare Inspections, Office of Inspector General, U.S. Department of Veterans Affairs
- Accompanied By:
- Andrea Buck, M.D., JD, Senior Physician, Medical Consultation and Review Division, Office of Healthcare Inspections, Office of Inspector General, U.S. Department of Veterans Affairs
- Randall Snow, Associate Director, Washington, DC, Regional Office, Office of Healthcare Inspections, Office of Inspector General, U.S. Department of Veterans Affairs
Panel 4
Submissions for the Record
- Gerald P. Koocher, Ph.D., Professor and Dean, School of Health Sciences, Simmons College, Boston, MA